Wed, December 11, 2019
Tue, December 10, 2019
Mon, December 9, 2019

Konstantinos Aprilakis Maintained (BPMC) at Hold with Decreased Target to $70 on, Dec 10th, 2019

Konstantinos Aprilakis of Deutsche Bank, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Decreased Target from $75 to $70 on, Dec 10th, 2019.

Konstantinos has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 1 agrees with Konstantinos's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Initiated at Hold and Held Target at $85 on, Thursday, August 29th, 2019


These are the ratings of the 3 analyists that currently disagree with Konstantinos


  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Decreased Target to $108 on, Wednesday, November 6th, 2019
  • Dane Leone of "Raymond James" Upgraded from Buy to Strong Buy on, Wednesday, November 6th, 2019
  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $100 on, Thursday, October 3rd, 2019